Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2024
Affiliations
Atea Pharmaceuticals (United States)(Current)
Maureen Montrond is an author at Atea Pharmaceuticals (United States).
Publications per year
2024–2024
First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus
Xiao-Jian Zhou, Jason D. Lickliter, Maureen Montrond et al. · Antimicrobial Agents and Chemotherapy · 2024 · 10 citations · Full text
1–1 of 1